Prevention of Anti-microbial Peptide LL-37-Induced Apoptosis and ATP Release in the Urinary Bladder by a Modified Glycosaminoglycan

• Won Yong Lee ,

  * E-mail: lee.wonyong@glycomira.com (WYL); glenn.prestwich@pharm.utah.edu (GDP)

  Affiliation GlycoMira Therapeutics, Inc. Salt Lake City, Utah, United States of America

  ⨯
• Justin R. Savage,

  Affiliation GlycoMira Therapeutics, Inc. Salt Lake City, Utah, United States of America

  ⨯
• Jianxing Zhang,

  Affiliations GlycoMira Therapeutics, Inc. Salt Lake City, Utah, United States of America, Department of Medicinal Chemistry and Center for Therapeutic Biomaterials, University of Utah, Salt Lake City, Utah, United States of America

  ⨯
• Wanjian Jia,

  Affiliation Department of Medicinal Chemistry and Center for Therapeutic Biomaterials, University of Utah, Salt Lake City, Utah, United States of America

  ⨯
• Siam Oottamasathien,

  Affiliations Department of Medicinal Chemistry and Center for Therapeutic Biomaterials, University of Utah, Salt Lake City, Utah, United States of America, Department of Surgery and Division of Pediatric Urology, University of Utah, Salt Lake City, Utah, United States of America

  ⨯
• Glenn D. Prestwich

  * E-mail: lee.wonyong@glycomira.com (WYL); glenn.prestwich@pharm.utah.edu (GDP)

  Affiliations GlycoMira Therapeutics, Inc. Salt Lake City, Utah, United States of America, Department of Medicinal Chemistry and Center for Therapeutic Biomaterials, University of Utah, Salt Lake City, Utah, United States of America

  ⨯